Clinical Trials Success
Sean reveals the low 4% success rate in clinical trials and explains the revenue model based on milestone payments. Lukas questions the sanity of relying on such a slim success margin, prompting Sean to elaborate on the strategy of growing revenue through multiple drug programs.In this clip
From this podcast
Gradient Dissent - A Machine Learning Podcast
Sean and Greg — Biology and ML for Drug Discovery
Related Questions